Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Shujin Decoction is a traditional Chinese medicine (TCM) herbal formula currently under clinical investigation for the treatment of fibromyalgia syndrome (FMS). Based on TCM principles, the formula is designed to "tonify the kidney" (Yishen) and "relax the tendons" (Shujin), addressing the chronic pain and musculoskeletal stiffness characteristic of fibromyalgia. The decoction is typically administered orally as granules. Clinical research, including randomized, double-blind, placebo-controlled trials led by investigators such as Juan Jiao, focuses on evaluating its efficacy in reducing pain intensity (measured by the Brief Pain Inventory) and improving overall health status and comorbidities. Mechanistic studies using brain structural and functional MRI are also being conducted to explore how the formula modulates central pain processing pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yishen Shujin Decoction.